|
|
||||||||
Articles |
1
Osaka City Environment and Public Health Association, Osaka 541-0055, Japan.
2
Department of Pediatrics, Osaka City University Medical
School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
a Author for correspondence. Fax 81-6-6636-8737; e-mail okano{at}med.osaka-cu.ac.jp
Background: The Beutler enzyme spot test is an effective assay for newborn mass screening of galactosemia, but it is qualitative and relies on visual interpretation. We describe a quantitative, instrumental modification of the assay.
Methods: We modified the macroscopic visual Beutler enzyme spot test by adding extraction of blood components from filter paper, deproteinization with acetone-methanol, and quantification and recording by a fluorescent microplate reader and personal computer. All handling was performed in microplates. The measurement time was 90 min.
Results: Fluorescence intensity (FI) of healthy controls correlated with hematocrit and galactose-1-phosphate uridyltransferase (GALT) activity. Patients with GALT deficiency were distinguished clearly from healthy subjects and heterozygous carriers by FI. FI decreased to 75% of the initial activity after storage at 25 °C for 3 days and to 40% after storage at 37 °C for 7 days. Screening of 46 742 newborns yielded 1 false-positive result (in a heterozygous carrier), 1 patient with glucose-6-phosphate dehydrogenase deficiency, and no apparent false negatives as judged by concurrent measurements of galactose and galactose-1-phosphate.
Conclusions: The quantitative Beutler test can provide precise GALT activity in newborn mass screening, and can take into consideration the influence of high temperature and humidity, duration between sampling and testing, and anemia. This method is clinically useful, simple, automated, and highly reliable for newborn mass screening of galactosemia.
The following articles in journals at HighWire Press have cited this article:
![]() |
J.-S. Jeong, H.-J. Kwon, Y.-M. Lee, H.-R. Yoon, and S.-P. Hong Galactosemia Screening by Simultaneous Blood Spot Quantification of Galactose and Galactose 1-Phosphate Clin. Chem., December 1, 2008; 54(12): 2080 - 2082. [Full Text] [PDF] |
||||
![]() |
K Murayama, H Nagasaka, K Tate, Y Ohsone, M Kanazawa, K Kobayashi, Y Kohno, and M Takayanagi Significant correlations between the flow volume of patent ductus venosus and early neonatal liver function: possible involvement of patent ductus venosus in postnatal liver function Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F175 - F179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Castro, R. Weber, V. Dadalt, V. F. Santos, G. J. Reclos, K. A. Pass, and R. Giugliani Evaluation of Glucose-6-Phosphate Dehydrogenase Stability in Blood Samples under Different Collection and Storage Conditions Clin. Chem., June 1, 2005; 51(6): 1080 - 1081. [Full Text] [PDF] |
||||
![]() |
U. G. Jensen, N. J. Brandt, E. Christensen, F. Skovby, B. Norgaard-Pedersen, and H. Simonsen Neonatal Screening for Galactosemia by Quantitative Analysis of Hexose Monophosphates Using Tandem Mass Spectrometry: A Retrospective Study Clin. Chem., August 1, 2001; 47(8): 1364 - 1372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |